Evidence map›Paper›PMID 29970055›Full record

ArticleBMC cancer2018

Nm23-H1 is involved in the repair of ionizing radiation-induced DNA double-strand breaks in the A549 lung cancer cell line.

Ya Sheng, Mingfang Xu, Chongyi Li, Yanli Xiong, Yi Yang, Xunjie Kuang, Dong Wang, Xueqin Yang

Open access · goldAbstract read
In one paragraph

Article in BMC cancer, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 20 citations in OpenAlex.

  1. Review
  2. Article
  3. NucleariScience · 2024
    Article
  4. NSUN6 Regulates NM23-H1 Expression in an m5C Manner to Affect Epithelial-Mesenchymal Transition in Lung Cancer.Medical principles and practice : international journal of the Kuwait University, Health Science Centre · 2024
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Expression of nm23-H1, p53, and integrin β1 in endometriosis and their clinical significance.International journal of clinical and experimental pathology · 2020
    Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Ya ShengCancer Center, Daping Hospital and Research Institute of Surgery, Army Military Medical University, No.10 Changjiang Zhi lu, Daping Yuzhong District, Chongqing, 400042, China.
Mingfang XuCancer Center, Daping Hospital and Research Institute of Surgery, Army Military Medical University, No.10 Changjiang Zhi lu, Daping Yuzhong District, Chongqing, 400042, China.
Chongyi LiCancer Center, Daping Hospital and Research Institute of Surgery, Army Military Medical University, No.10 Changjiang Zhi lu, Daping Yuzhong District, Chongqing, 400042, China.
Yanli XiongCancer Center, Daping Hospital and Research Institute of Surgery, Army Military Medical University, No.10 Changjiang Zhi lu, Daping Yuzhong District, Chongqing, 400042, China.
Yi YangCancer Center, Daping Hospital and Research Institute of Surgery, Army Military Medical University, No.10 Changjiang Zhi lu, Daping Yuzhong District, Chongqing, 400042, China.
Xunjie KuangCancer Center, Daping Hospital and Research Institute of Surgery, Army Military Medical University, No.10 Changjiang Zhi lu, Daping Yuzhong District, Chongqing, 400042, China.
Dong WangCancer Center, Daping Hospital and Research Institute of Surgery, Army Military Medical University, No.10 Changjiang Zhi lu, Daping Yuzhong District, Chongqing, 400042, China.
Xueqin YangCancer Center, Daping Hospital and Research Institute of Surgery, Army Military Medical University, No.10 Changjiang Zhi lu, Daping Yuzhong District, Chongqing, 400042, China. yangxueqin@hotmail.com.
Daping Hospital · CN

Funding

National Natural Science Foundation of China 81272599
6 · The paper itself

Abstract

backgroundAlthough originally identified as a putative metastasis suppressor, increasing studies have confirmed a possible role for Nm23-H1 in DNA repair, through the base excision repair and nucleotide excision repair pathways. In this study, we explored whether Nm23-H1 was also involved in double-strand break repair (DSBR). METHODS AND

resultsWe constructed a stable A549-shNm23-H1 cell line with doxycycline-regulated expression of Nm23-H1, and a A549-nNm23-H1 cell line that over expressed a nucleus-localized version of Nm23-H1. Results from both lines confirmed that Nm23-H1 participated in the repair of double-strand breaks induced by X-rays, using Comet and γ-H2AX foci assays. Subsequent studies showed that Nm23-H1 activated the phosphorylation of checkpoint-related proteins including ATM serine/threonine kinase (on S1981), tumor protein p53 (on S15), and checkpoint kinase 2 (Chk2) (on T68). We also detected interactions between Nm23-H1 and the MRE11-RAD50-NBS1 (MRN) complex, as well as Ku80. Moreover, NBS1 and Ku80 levels were comparably higher in Nm23-H1 overexpressing cells than in control cells (t = 14.462, p < 0.001 and t = 5.347, p = 0.006, respectively). As Ku80 is the keystone of the non-homologous end joining (NHEJ) pathway, we speculate that Nm23-H1 promotes DSBR through NHEJ.

conclusionsThe results indicate that Nm23-H1 participates in multiple steps of DSBR.

Indexed as

DNA Breaks, Double-StrandedDNA RepairA549 CellsDNA End-Joining RepairHumansLung NeoplasmsNM23 Nucleoside Diphosphate KinasesPhosphorylationRecombinational DNA RepairX-RaysNM23 Nucleoside Diphosphate KinasesNME1 protein, humanDouble-strand break repairLung cancerNm23-H1

Identifiers

PMID29970055
PMCPMC6029351
OpenAlexW2810280974

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.